VirPath
Management
SARS-CoV-2 (2020-2023)
News - Last semester of 2023
News - first semester of 2023
News - last semester of 2022
------------------------------
Integrative approach to influenza virus surveillance characterization and control
Collaborators
Publications
Thesis
------------------------------
Molecular and cellular signature of respiratory viruses, innovative antivirals and vaccines
Theme #1
Theme #2
Scientific production
Publications
Theses
Patents
Grants and funding
Collaborators
Partners
Fun
------------------------------
Collaborative projects, Consortiums and Partnership
------------------------------
Virnext spin-off
VirHealth SAS
Signia Therapeutics
Vaxxel
VirexpR
AIS Biotech
Nexomis
------------------------------
Contact
Virology and human Pathology
VirPath
Management
SARS-CoV-2 (2020-2023)
News - Last semester of 2023
News - first semester of 2023
News - last semester of 2022
------------------------------
Integrative approach to influenza virus surveillance characterization and control
Collaborators
Publications
Thesis
------------------------------
Molecular and cellular signature of respiratory viruses, innovative antivirals and vaccines
------------------------------
Collaborative projects, Consortiums and Partnership
------------------------------
Virnext spin-off
VirHealth SAS
Signia Therapeutics
Vaxxel
VirexpR
AIS Biotech
Nexomis
------------------------------
Contact
Anciens Collaborators
Caroline Picard
M2
Email :
caroline.picard01@chu-lyon.fr
Défiler vers le haut
fermer
